Inhibition of the proteasome system stimulated osteoblastogenesis and bone formation in calvariae in mice and in multiple myeloma patients, at least in part through the stimulation of bone morphogenetic protein-2 (BMP-2) gene expression and the inhibition of Runx2 proteolytic degradation [19,20,21]. The gene discussed is BMP2; the disease is plasma cell myeloma.